Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nickolas Papadopoulos

Showing results (11-20 of 183) with videos related to

Pageof 19
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2016
Evaluating the evaluation of cancer driver genesCollin J Tokheim, Nickolas Papadopoulos, Kenneth W Kinzler, et al.
Science (New York, N.Y.)|December 6, 2008
The antisense transcriptomes of human cellsYiping He, Bert Vogelstein, Victor E Velculescu, et al.
Genes & Development|October 31, 2015
Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancersJosh Lewis Stern, Dan Theodorescu, Bert Vogelstein, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 9, 2020
Tumor DNA as a Cancer Biomarker through the Lens of Colorectal NeoplasiaJoshua D Cohen, Brenda Diergaarde, Nickolas Papadopoulos, et al.
Science Translational Medicine|August 30, 2019
Applications of liquid biopsies for cancerAustin K Mattox, Chetan Bettegowda, Shibin Zhou, et al.
Cancer|February 8, 2022
Multicancer early detection test: Preclinical, translational, and clinical evidence-generation plan and provocative questionsJohn B Kisiel, Nickolas Papadopoulos, Minetta C Liu, et al.
Science (New York, N.Y.)|March 30, 2013
Cancer genome landscapesBert Vogelstein, Nickolas Papadopoulos, Victor E Velculescu, et al.
The New England Journal of Medicine|December 10, 2025
Molecular Evidence of Multiorgan Damage in Patients with Immune-Related Adverse EventsYuxuan Wang, Howard L Li, Chetan Bettegowda, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2009
A panel of isogenic human cancer cells suggests a therapeutic approach for cancers with inactivated p53Surojit Sur, Raymond Pagliarini, Fred Bunz, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2017
Selected reaction monitoring approach for validating peptide biomarkersQing Wang, Ming Zhang, Tyler Tomita, et al.
Pageof 19

Showing results (11-20 of 183) with videos related to

Sort By:
Pageof 19
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2016
Evaluating the evaluation of cancer driver genesCollin J Tokheim, Nickolas Papadopoulos, Kenneth W Kinzler, et al.
Science (New York, N.Y.)|December 6, 2008
The antisense transcriptomes of human cellsYiping He, Bert Vogelstein, Victor E Velculescu, et al.
Genes & Development|October 31, 2015
Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancersJosh Lewis Stern, Dan Theodorescu, Bert Vogelstein, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 9, 2020
Tumor DNA as a Cancer Biomarker through the Lens of Colorectal NeoplasiaJoshua D Cohen, Brenda Diergaarde, Nickolas Papadopoulos, et al.
Science Translational Medicine|August 30, 2019
Applications of liquid biopsies for cancerAustin K Mattox, Chetan Bettegowda, Shibin Zhou, et al.
Cancer|February 8, 2022
Multicancer early detection test: Preclinical, translational, and clinical evidence-generation plan and provocative questionsJohn B Kisiel, Nickolas Papadopoulos, Minetta C Liu, et al.
Science (New York, N.Y.)|March 30, 2013
Cancer genome landscapesBert Vogelstein, Nickolas Papadopoulos, Victor E Velculescu, et al.
The New England Journal of Medicine|December 10, 2025
Molecular Evidence of Multiorgan Damage in Patients with Immune-Related Adverse EventsYuxuan Wang, Howard L Li, Chetan Bettegowda, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2009
A panel of isogenic human cancer cells suggests a therapeutic approach for cancers with inactivated p53Surojit Sur, Raymond Pagliarini, Fred Bunz, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2017
Selected reaction monitoring approach for validating peptide biomarkersQing Wang, Ming Zhang, Tyler Tomita, et al.
Pageof 19